Align Technology Inc (ALGN) Financial Statements

Historical financial data — 42 statements covering FY2016–FY2025

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90%...

Align Technology Inc's revenue increased 0.9% year over year, from $4.00B to $4.03B.

Net income decreased 2.6% over the same period, from $421.4M to $410.4M.

Over the 9-year period from FY2016 to FY2025, revenue grew by 274% in total.

Operating cash flow declined 19.6% to $593.2M.

Align Technology Inc maintains a healthy net profit margin of 10.2%.

Recent Financial Statements

Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).

PeriodRevenueNet IncomeGross ProfitEBITOp. Cash FlowTotal AssetsEquity
Q3 FY2024$977.9M-4.9%$116.0M$681.8M$162.3M$263.7M$6.37B$3.94B
Q4 FY2024$995.2M+1.8%$103.8M$696.9M$144.1M$286.1M$6.21B$3.85B
Q1 FY2025$979.3M-1.6%$93.2M$680.1M$131.1M$52.7M$6.10B$3.79B
Q2 FY2025$1.01B+3.4%$124.6M$708.1M$163.0M$128.7M$6.22B$3.91B
Q3 FY2025$995.7M-1.7%$56.8M$639.2M$96.3M$188.7M$6.23B$3.96B
Q4 FY2025$1.05B+5.2%$135.8M$683.6M$155.3M$223.2M$6.23B$4.05B
Q1 FY2026$1.04B-0.7%$112.8M$736.6M$142.0M$151.0MN/AN/A
Q2 FY2026$1.06B+1.5%$108.3M$757.4M$154.0M$192.8MN/AN/A

Balance Sheet Summary (FY2025)

Total Assets
$6.23B
Total Liabilities
$2.18B
Total Equity
$4.05B
Cash & Equivalents
$1.09B
Total Debt
N/A
Current Assets
$2.62B
Current Liabilities
$1.92B
Retained Earnings
$2.46B
Current Price: $147.45
Market Cap: $10.5B
Sector: Healthcare

Align Technology Inc (ALGN) Financial Statements & Revenue History

Align Technology Inc (ALGN) is a US-listed stock operating in the Healthcare sector, specifically the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry trading at $147.45 with a market capitalization of $10. This page provides 42 historical financial statements for Align Technology Inc, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Align Technology Inc reported revenue of $4.0 billion, representing 0.9% year-over-year growth. The net profit margin of 10.2% indicates moderate profitability..

ALGN Income Statement, Balance Sheet & Cash Flow

The financial statements table above shows Align Technology Inc's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether ALGN is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.

  • Revenue trend: Track ALGN's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
  • Profitability: Net income and gross profit margins reveal how efficiently Align Technology Inc converts revenue into earnings.
  • Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of ALGN's financial position and leverage.
  • Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.

How to Use ALGN Financial Data

Investors use Align Technology Inc's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:

Financial data is sourced from Align Technology Inc's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.ALGN trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Healthcare
More Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks
Cheaper alternatives
Similar fundamentals